Drugs Archives - Page 32 of 65 - ��ϳԹ�� News

KHN’s ‘What The Health?’: SCOTUS Decides An ACA Case. No, Not THAT Case.

The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act’s “risk corridors” provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Carmen Heredia Rodriguez, who wrote the latest KHN-NPR “Bill of the Month” installment about COVID testing that should have been free but was not.

April 30, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

April 24, 2020

Amid Pandemic, FDA Seizes Cheaper Drugs From Canada

Many Americans order drugs from Canada and other countries because they are cheaper, but U.S. authorities appear to be cracking down on the practice.

By Phil Galewitz

April 20, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

April 17, 2020

Podcast

KHN’s ‘What The Health?’: How Will We Reopen The Economy?

The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

April 16, 2020

With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’

The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.

By Michelle Andrews

April 16, 2020

COVID-19

‘You Pray That You Got The Drug.’ Ailing Couple Gambles On Trial For COVID-19 Cure

Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.

By JoNel Aleccia

April 6, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

April 3, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

March 27, 2020

COVID-19

Why Hoarding Of Hydroxychloroquine Needs To Stop

Six states — Idaho, Louisiana, Nevada, North Carolina, Ohio and Texas — have taken steps to limit inappropriate prescriptions for the medicine and preserve supplies for patients who take it for lupus and rheumatoid arthritis.

By Martha Bebinger, WBUR

March 25, 2020

Pharma Cash To Congress

Senators Who Led Pharma-Friendly Patent Reform Also Prime Targets For Pharma Cash

Three senators on a revived subcommittee received more than $100,000 each from drugmakers.

By Emmarie Huetteman

March 24, 2020

COVID-19

Mask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure

Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks.

By Christina Jewett and Sydney Lupkin, NPR News

March 20, 2020

Heart Association Puts Halt To Bayer’s Giant Displays Of Baby Aspirin

After Kaiser Health News’ questions, the association tells the aspirin maker to take down display bins at Walmart pharmacies that gave a false impression that the over-the-counter drug is recommended for everyone to prevent heart attacks.

By Phil Galewitz

March 10, 2020

Colorado Forges Ahead On A New Model For Health Care While Nation Waits

Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.

By Markian Hawryluk

Feb. 28, 2020

Letters to the Editor

Readers And Tweeters Dive Into Debate Over ‘Medicare For All’

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Feb. 28, 2020

COVID-19

As The Coronavirus Spreads, Americans Lose Ground Against Other Health Threats

Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.

By Liz Szabo

Feb. 26, 2020

Congressional Candidates Go Head-To-Head On Health Care — Again

The California Democratic members of Congress who flipped seven Republican seats two years ago made health care a major campaign issue, criticizing their opponents for voting to repeal the Affordable Care Act. As the Democrats defend their seats in this year’s elections, they are coming back to health care — but the issues are different.

By Ana B. Ibarra

Feb. 24, 2020